ABOUT US
The Company


A company committed to developing life-saving vaccines using a novel technology
Vaxdyn was founded in 2011 as a spin-off established by researchers of the Institute of Biomedicine of Seville, a center of the Andalusian Public Health System and the University of Seville linked to the University Hospital Virgen del Rocío of Seville.
We work with an international network of collaborators on development of multi-valent vaccines for preventing antibiotic-resistant infections in all regions of the world.
Our vaccines target high-risk populations, populations affected by chronic diseases of the lungs, liver, kidney, immunocompromised by co-morbidities like diabetes or cancer, populations associated with nursing homes and hospital settings, women affected by recurrent urinary-tract infections, or neonates.
CONTACT
Vaxdyn
Supported by










